Universitair Ziekenhuis Leuven (UZL)                                                

Website:
https://www.uzleuven.be/nl/multipel-myeloom-mm

The Chronic lymphocytic leukemia (CLL) patients registry (CLLEAR) is a registry hosted by the Czech CLL Study Group and the Czech Leukemia Study group and collects deep insights of medical records of CLL patients from 10 Czech Republic hospitals and centers.

Website:
https://www.leukemia-cell.org/index-en.php?pg=cllear

The Registry of Monoclonal Gammopathies (RMG), established by the Czech Myeloma Study Group (CMG), is a registry designed for the collection of clinical data from 23 CZ and SK Hematology centers concerning diagnosis, treatment, treatment results and survival of patients with MGUS, MM, and SMM.

Website:
https://rmg.healthregistry.org/

The University Hospital Center of Dijon Bourgogne is a large center that offers public emergency service, diagnosis, care and prevention. CHU Dijon is well-establihed in the provision of first-class and comprehensive hematological malignancy treatment, and is the only center in the Burgundy region that has the capabilities to provide heavy therapy treatment for certain blood diseases.

Website:
https://www.chu-dijon.fr/

With nearly 16,000 professionals and being made up of 13 establishments, the Lille University Hospital Center is one of the largest public health establishments in Northern Europe. CHU Lille is committed to scientific excellence in the service of innovation, progress and the transformation of practices and organizations, and focuses on various research areas, including cancer research.

Website:
https://www.chu-lille.fr/

CHU Montpellier is a French University hospital center focused on care, teaching and research, but also prevention, health education and the fight against social exclusion. It is organized around 13 university hospital centers grouping all medical and surgical specialties and spread over several geographical sites north-east of Montpellier.

Website:
https://www.chu-montpellier.fr/

The hematology department of CHU Nice specializes in the management of blood and lymph node disorders, including cancers. It develops recourse activities such as allogeneic and autologous hematopoietic stem cell transplantation, intensive chemotherapy, and clinical research, allowing for access to innovative treatments.

The IUCT Oncopole comprises the Institut Claudius Regaud, a cancer center, and several teams from Toulouse University Hospital Center. The two institutions offer the expertise of 1500 professionals specialized in oncology on the same site. The site specializes in a variety of rare and complex diseases, including haematological cancers, and has a large medical database on various blood cancers.

Website:
https://www.iuct-oncopole.fr/

iOMEDICO is a German clinical research institute and clinical research organization that works with a large, intersectoral network of hospitals and private clinics in Germany, and specializes in interventional and real-world data studies in oncology and hematology. HONEUR works with two of iOMEDICO's registry platforms that predominantly collect longitudinal data on myeloma and lymphoma patients.

Website:
https://www.iomedico.com/

Since it was founded in 1997, Oncology at Sachsenring has built up a close network of cooperation partners and its own study center. The oncologists at the MVZ Study Center Cologne are committed to holistic treatment of a malignant disease and are therefore the primary contact for all aspects of cancer. In the spirit of "holistic care", Oncology Cologne have therefore developed some additional offers, which include social counseling, psychosocial care, nutritional therapy, sports offers and others. Furthermore, oncology Cologne works very closely in various tumor conferences with several hospitals and all-important specialist disciplines.

Website:
https://www.onkologie-koeln.de/

TriNetX Oncology GmbH collaborates with renowned medical experts and pharmaceutical leaders to generate fit-for-purpose database specifications to match the desired study objectives scoping for oncology and rare disease indications. By gathering complete, representative, and high-quality data, TherapyMonitor reflects the variety of cancer care across the continent.

Website:
https://trinetx.com/products/consulting-services/tnxogmbh/

The University Hospital Würzburg> is a pioneer in medical care, research and teaching. Their hematology department is very research-oriented, and focuses on the development of new therapeutic approaches. With their Multiple Myeloma sstudy group that consists of more than 2500 patients, they are partiuclarly strong in Multiple Myeloma research.

Website:
https://www.ukw.de/startseite/

The Hospital Healthcare company Ovest Milanese is a public organization that includes 4 entities in an area near Milan. Its Division of Hematology, placed in the new Hospital Legnano can count on a group of experts with a well-proven track record in a variety of onco-haematological disease, such as myeloma, lymphomas, and leukemia. It collaborates within national and international networks and actively participates in research projects and trials mainly in lymphomas and myelomas.

The Hematology department at Ospedale Maggiore Policlinico of Milan specialises in the clinical management of benign and malignant hematology disorders. Within the largest public research hospital in Italy, the hematology department performs basic, translational and clinical research in myeloma, myeloid, and lymphoid malignancies, with a special focus on disease pathogenesis and genomic predictors of clinical outcomes.

The Romagnolo Institute for the Study of Tumors "Dino Amadori" - IRST is a center of excellence entirely dedicated to treatment, research and training in the oncology field. Since its inauguration in 2007, IRST IRCCS has broken new ground in multiple areas of cancer research, with clinical, research programs, and high-level training and education initiatives. The center has a strong interest in hematological research and collects medical patient records on a variety of blood cancers.

Website:
https://www.irst.emr.it/it/

The Kazakh Research Institute of Oncology & Radiology is responsible for all cancer control programs in Kazakhstan. The institute provides a multidisciplinary approach to cancer treatment, education and training. They play a big role in cancer policy in Kazakhstan.

Website:
https://www.uicc.org/membership/kazakh-institute-oncology-and-radiology

Maastricht University Medical Center+ (NL)          

IMIM (Hospital del Mar Medical Research Institute) is a research-focused institute that consists of 60 research groups, of which two are specifically focused on haematological (lymphoid and myeloid) research. They collect patient data on a variety of haematological malignancies, with a predominant focus on lymphomas. The hospital is one of the biggest sites in Spain in eHealth research, which is also actively contributing to other projects such as EHDEN and HARMONY.

Website:
https://www.parcdesalutmar.cat/en/hospitals/hospital-del-mar/

Health Research Institute Hospital La Fe is a public sector initiative made up of 6 entities within the Valencia region. Its Hematology Research Group has a well-proven track record, collaborates with a variety of national and international partners on especially leukemia research projects.

Website:
http://www.hospital-lafe.com/

Lozano Blesa University Hospital is part of IIS Aragón, a Health Research Institute for the Health Department of the Aragón regional Government. The Lozano Blesa Hematology Study Group focuses on hematoncology malignancies and iomunotherapy in translational lymphoma research.

Website:
https://www.iisaragon.es/

The Research Institute Hospital 12 de Octubre is conceived as a functional structure of multidisciplinary and translational biomedical research focused on basic, clinical, epidemiological and health service research.

Website:
https://imas12.es/en/the-institute/welcome/

Tel Aviv Sourasky Medical Center's division of hematology provides expert care for patients with a variety of blood disorders, including malignant hematological diseases such as acute and chronic leukemias, MDS (myelodysplastic syndromes), multiple myeloma, and Hodgkin's and non-Hodgkin's lymphoma, and is affiliated with the Sackler Faculty of Medicine of the Tel Aviv University for leading-edge scientific and clinical research and ongoing medical education.

Website:
https://www.tasmc.org.il/sites/en/Pages/default.aspx

Cancer Centre London (CCL) is at the forefront of innovative cancer care and a recognised Centre of Excellence. The centre has a well-established Haemato-Oncology Unit where they treat a wide range of haematological disorders, including leukemia, lymphoma, and myeloma.

Website:
https://cancercentrelondon.co.uk/

University Hospitals Leicester NHS is one of the biggest and busiest NHS Trusts in the country, and works with many different organisations throughout the world to push the boundaries of research. They deliver a wide range of Cancer and Haematology National Institute of Health Research (NIHR) studies and are part of the Myeloma UK Clinical Trials Network.

Website:
https://www.leicestershospitals.nhs.uk/

Cardiff and Vale University Health Board includes the University Hospital of Wales and has strong links to Cardiff University. UHW is a large 900 bed teaching hospital in the capital city of Wales which provides haematological cancer care for the surrounding population. UHW has a strong track record in clinical trial and routine NHS care.

Website:
https://cavuhb.nhs.wales/about-us/

The Royal Wolverhampton NHS Trust (UK)